NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
Back to search
Official data from USPTO
HCW BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
HCW BIOLOGICS
ST13
US500000097033394Class
42
Filing
97033394
Registration
7021995
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
04/11/2023
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
09/17/2021
Registration date
04/11/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
04/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/28/2018
First use in commerce
05/28/2018
Drawing code
4
Owner type
03
Owner location
Miramar, FL, US
Examiner
FOSDICK, GEOFFREY A
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HCW Biologics Inc.
Representatives
Cynthia J. Walden FISH & RICHARDSON PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of platform technology, namely, immunotherapy pharmaceutical platforms for use in manufacturing therapeutics related to inflammaging, inflammatory diseases, age-related diseases and cancer; Medical and scientific research and development services in the field of protein therapeutics and immunotherapeutics; pharmaceutical product development; pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of age-related and inflammatory diseases and cancer
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/24/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/22/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/22/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/22/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2022
GNRT
NON-FINAL ACTION E-MAILED
06/23/2022
CNRT
NON-FINAL ACTION WRITTEN
06/23/2022
DOCK
ASSIGNED TO EXAMINER
06/21/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/28/2021
ALIE
ASSIGNED TO LIE
10/28/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/22/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/05/2021
NWAP
NEW APPLICATION ENTERED
09/21/2021
Continuous trademark protection
Get notified about every new filing that threatens HCW BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.